Literature DB >> 12996494

Bacteriologic studies in an outbreak of salmonellosis in Korea, with special attention to Salmonella paratyphi and perforations of paratyphoid ulcers.

L E ZIMMERMAN, M COOPER, C D GRABER.   

Abstract

Entities:  

Keywords:  SALMONELLA INFECTIONS/epidemiology and statistics

Mesh:

Year:  1952        PMID: 12996494     DOI: 10.1093/oxfordjournals.aje.a119550

Source DB:  PubMed          Journal:  Am J Hyg        ISSN: 0096-5294


× No keyword cloud information.
  6 in total

Review 1.  Salmonella enterica serotype Typhimurium and its host-adapted variants.

Authors:  Wolfgang Rabsch; Helene L Andrews; Robert A Kingsley; Rita Prager; Helmut Tschäpe; L Garry Adams; Andreas J Bäumler
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

2.  Relapsing fever in Korea; a clinicopathologic study of eleven fatal cases with special attention to association with Salmonella infections.

Authors:  T R ANDERSON; L E ZIMMERMAN
Journal:  Am J Pathol       Date:  1955 Nov-Dec       Impact factor: 4.307

3.  Small bowel perforation secondary to enteric Salmonella paratyphi A infection.

Authors:  J A Dunne; J Wilson; J Gokhale
Journal:  BMJ Case Rep       Date:  2011-04-19

4.  Human infection with Salmonella choleraesuis in Hong Kong.

Authors:  C T Huang; C B Lo
Journal:  J Hyg (Lond)       Date:  1967-06

5.  Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls.

Authors:  E Konadu; J Shiloach; D A Bryla; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

6.  Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam.

Authors:  E Y Konadu; F Y Lin; V A Hó; N T Thuy; P Van Bay; T C Thanh; H B Khiem; D D Trach; A B Karpas; J Li; D A Bryla; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.